TRVI Trevi Therapeutics

Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Gainers COMSovereign Holding Corp. (NASDAQ:COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday.Kalera Public Limited Company (NASDAQ:KAL) rose 30% to $0.118

11-23 20:41

Trevi Therapeutics (NASDAQ:TRVI) Receives New Coverage From Analysts at SVB Leerink

SVB Leerink assumed coverage on shares of Trevi Therapeutics (NASDAQ:TRVI – Get Rating) in a report released on Tuesday, MarketBeat Ratings reports. The firm issued an outperform rating and a $6.00 t

11-23 18:02

Trevi Therapeutics Initiated at Outperform by SVB Leerink

Trevi Therapeutics Initiated at Outperform by SVB Leerink

11-22 19:25

Trevi Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 11/22/2022 201.51% SVB Leerink → $6 Initiates Coverage On → Outperform 11/11/2022 302.01% Needham $10 → $8

11-22 19:16

SVB Leerink Initiates Coverage On Trevi Therapeutics With Outperform Rating, Announces Price Target of $6

SVB Leerink analyst Thomas Smith initiates coverage on Trevi Therapeutics (NASDAQ:TRVI) with a Outperform rating and announces Price Target of $6.

11-22 19:15

Oppenheimer Lowers Trevi Therapeutics (NASDAQ:TRVI) Price Target to $9.00

Trevi Therapeutics (NASDAQ:TRVI – Get Rating) had its target price lowered by investment analysts at Oppenheimer to $9.00 in a research note issued on Thursday, Stock Target Advisor reports. Oppenhe

11-19 15:51

Oppenheimer Research Analysts Cut Earnings Estimates for Trevi Therapeutics, Inc. (NASDAQ:TRVI)

Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Rating) – Research analysts at Oppenheimer cut their FY2022 earnings per share (EPS) estimates for shares of Trevi Therapeutics in a research report issu

11-19 15:11

Oppenheimer Adjusts Trevi Therapeutics Price Target to $9 From $12 Mainly on Higher Discount Rate, Maintains Outperform Rating

10:51 AM EST, 11/15/2022 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co

11-15 23:53

Trevi Therapeutics Appoints David Clark as Chief Medical Officer >TRVI

Trevi Therapeutics Appoints David Clark as Chief Medical Officer >TRVI

11-15 05:08

Trevi Therapeutics: Clark to Lead Continued Development of Haduvio to Treat Chronic Cough >TRVI

Trevi Therapeutics: Clark to Lead Continued Development of Haduvio to Treat Chronic Cough >TRVI

11-15 05:08